Tag: emtricitabine

1. Dolutegravir-based antiretroviral therapy regimens effectively suppressed maternal viral load during pregnancy, supporting their use to prevent vertical transmission. 2. Dolutegravir, emtricitabine, and tenofovir alafenamide fumarate carried relatively low risk of adverse fetal outcomes. Evidence Rating Level: 1 (Excellent) Study Rundown: Initiation of antiretroviral therapy (ART) for pregnant women infected with HIV-1...
1. HIV-1 acquisition rates were significantly lower in men who used tenofovir-disoprovil fumarate (TDF) and emtricitabine (FTC) preexposure prophylaxis (PrEP). 2. TDF-FTC was associated with significantly higher rates of gastrointestinal (GI) complaints and elevated serum creatinine levels. Evidence Rating Level: 1 (Excellent) Study Rundown: Studies have shown potential for effective PrEP of...
Image: PD 1. A significantly higher percentage of patients taking tenofovir, emtricitabine, and efavirenz had HIV viral load <50 copies/mL than those taking zidovudine, lamivudine, and efavirenz 2. Significantly more patients discontinued medication in the zidovudine-lamivudine group due to adverse events than in the tenofovir-emtricitabine group Original Date of Publication: January 19,...